November 2022
Corporate HQ
Baltimore, Maryland

Founded in 2004, Sapio Sciences has established a best in class, highly scalable technology solution addressing the Laboratory Information Management (LIMS), Electronic Laboratory Notebooks (ELN) and Scientific Data Management (SDMS) markets. A US based high growth, leading lab informatics platform, Sapio serves Biopharma, CRO’s and diagnostic labs, optimally positioned in high growth areas including bioanalysis, ATMP’s and genomic sequencing.

Sapio serves a broad customer base, including blue-chip customers throughout the United States with additional footholds in Europe and Japan.

Enablement & Alignment

Shared vision to grow a highly scalable, best in class lab informatics platform on global scale addressing high growth market demanding new data driven and fit for purpose AI assisted lab informatics technologies

Capability & Capacity

Identifying and investing in multiple avenues for organic growth and product development in particular, new modalities for both small and large molecules through AI and machine learning to support an increasingly complex drug development landscape.

Investment into Commercial function and Business Development to build a focused commercial go-to-market strategy, growing existing client base and unlocking significant white space in the market.

Building Strategic Footprints

Leveraging GHO's experience and network to consolidate a fragmented lab informatics market with a focus on expansion into Europe to service unmet customer demand and scale the business globally